TY  - JOUR
AU  - Fernández Trapero, María
AU  - Pérez Díaz, Carmen
AU  - Espejo Porras, Francisco
AU  - Lago Femia, Eva De
AU  - Fernández Ruiz, Javier
PY  - 2020
DO  - 10.3390/biom10020279
SN  - 2218-273X
UR  - https://hdl.handle.net/20.500.14352/7928
T2  - Biomolecules
AB  - The phytocannabinoid-based medicine Sativex® is currently marketed for the treatment of spasticity and pain in multiple sclerosis patients and is being investigated for other central and peripheral pathological conditions. It may also serve in...
LA  - eng
M2  - 279
PB  - MDPI
KW  - Pharmacokinetics
KW  - Sublingual delivery
KW  - Sativex®
KW  - Cannabidiol
KW  - ∆9-tetrahydrocannabinol
KW  - Naïve dogs
TI  - Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders
TY  - journal article
VL  - 10
ER  -